Levine Cancer Institute-Ballantyne — Charlotte, North Carolina

Levine Cancer Institute-Ballantyne is a clinical research site located in Charlotte, North Carolina, United States 28277.

Crixeo Clinical Trials Trust Score: 25/100 (FAILING). This profile has not yet been claimed by the site owner.

Levine Cancer Institute-Ballantyne has participated in 34 clinical trials with 27 currently active.

Therapeutic areas: Pancreatic Adenocarcinoma, Borderline Resectable Adenocarcinoma of the Head of the Pancrease, Breast Cancer.

Sponsors: Alliance for Clinical Trials in Oncology, NRG Oncology, Canadian Cancer Trials Group.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Charlotte

Browse all research sites in North Carolina · View every site in Charlotte

Sponsor Feasibility Report

Trust Score: 25/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Levine Cancer Institute-Ballantyne?

Levine Cancer Institute-Ballantyne has a Crixeo Trust Score of 25/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Levine Cancer Institute-Ballantyne conducted?

Levine Cancer Institute-Ballantyne has 34 clinical trials on record, with 27 currently active. Their work covers Pancreatic Adenocarcinoma, Borderline Resectable Adenocarcinoma of the Head of the Pancrease, Breast Cancer.

Is Levine Cancer Institute-Ballantyne accredited by Crixeo Clinical Trials?

Levine Cancer Institute-Ballantyne has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Levine Cancer Institute-Ballantyne?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.